AKT1 and non-small cell lung carcinoma: These results demonstrated that STUB1 acted as an intermediate effector molecule in the regulation of Akt1 degradation in CRTAC1-overexpressed cells upon cisplatin treatment, thereby playing an important role in the CRTAC1-mediated regulation of the chemosensitivity of NSCLC to cisplatin treatment.